Sorry, this activity has expired and is no longer available for CME credit. You may still enjoy the program.
CME Information
Provider Statement: This continuing medical education activity is provided by 
.
Support Statement: This activity is supported by an educational grant from Sanofi US and Regeneron Pharmaceuticals.
Target Audience: The intended audience for this activity is cardiology fellows and other health care professionals involved in the treatment of patients with CVD.
Learning Objectives: Upon successful completion of this activity, participants should be better able to:
- Review the methods for advanced lipid testing and genetic screening to better characterize the underlying cause of dyslipidemia and guide clinical decision-making.
- Assess evidence-based low-density lipoprotein cholesterol (LDL-C)-lowering treatment guidelines to reduce CVD risk in patients with dyslipidemia.
- Evaluate the safety and efficacy of very low LDL-C levels that can be achieved with proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.
- Outline strategies that can be used to increase patient engagement and improve shared decision-making.
- Examine appropriate strategies for the management of multiple CVD risk factors and implications for polypharmacy.
Activity Chair:
Michael H. Davidson, MD, FACC, FACP, FNLA, FASPC
Professor of Medicine
Director of the Lipid Clinic
The University of Chicago Pritzker School of Medicine
Chicago, IL
Faculty:
David J. Davidson, MD, FACC
Clinician Educator
NorthShore Medical Group
Evanston, IL
Martha Gulati, MD, MS, FACC, FAHA, FASPC
Professor of Medicine
Chief of Cardiology, University of Arizona College of Medicine - Phoenix
Editor-in-Chief, CardioSmart for The American College of Cardiology
Phoenix, AZ
Carl E. Orringer, MD, FACC, FNLA
Associate Professor of Medicine
Director of Preventive Cardiovascular Medicine
University of Miami Miller School of Medicine
Miami, FL
Matthew J. Sorrentino, MD, FACC, FAHA
Professor of Medicine
Vice Chair for Clinical Operations
Department of Medicine
Section of Cardiology
University of Chicago Medicine
Chicago, IL
Laurence S. Sperling, MD, FACC, FACP, FAHA, FASPC
Director, Preventive Cardiology at Emory Clinic
Katz Professor of Preventive Cardiology
Emory University School of Medicine
Professor of Global Health
Rollins School of Public Health at Emory University
Atlanta, GA
Reviewer:
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, January 21, 2020, to January 20, 2021.
How To Participate in This Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, view the content, and complete the CME posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 4 out of 5 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears below.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Activity Chair and Faculty report the following relationships:
David J. Davidson, MD, FACC
Consulting Fee: Akcea, Amgen, Regeneron, Sanofi
Michael H. Davidson, MD, FACC, FACP, FNLA, FASPC
Consulting Fee: Amgen, Novo Nordisk, Regeneron, Sanofi
Speakers Bureau: Amgen, Novo Nordisk, Regeneron, Sanofi
Martha Gulati, MD, MS, FACC, FAHA, FASPC
No relevant financial relationships to disclose.
Carl E. Orringer, MD, FACC, FNLA
No relevant financial relationships to disclose.
Matthew J. Sorrentino, MD, FACC, FAHA
No relevant financial relationships to disclose.
Laurence S. Sperling, MD, FACC, FACP, FAHA, FASPC
No relevant financial relationships to disclose.
Reviewer reports the following relationship(s):
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationship to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2020 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com